Dr. Len Walt Joins CannTrust executive team as Chief Medical Officer

Published: May 17, 2019

CannTrust Holdings Inc. strengthened its senior leadership team with the appointment of Dr. Len Walt, M.D., MBA, to the newly created position of Chief Medical Officer (“CMO”). Dr. Walt will lead the global medical function dedicated to strengthening CannTrust’s clinical research strategy, medical education programs, product innovation and support the expansion of CannTrust’s global medical businesses and partnerships.

“Adding Dr. Walt to our senior leadership team supports our commitment to developing a world-class global medical function that will drive our international growth and partnership strategy,” said Peter Aceto, Chief Executive Officer, CannTrust. “As we continue to grow, Dr. Walt’s leadership and experience will be pivotal to ensure we continue our commitment to industry-leading research and product development.”

Dr. Walt comes to CannTrust with extensive senior leadership experience in the pharmaceutical and biotechnology industries in Canada, USA and abroad. Most recently Dr. Walt held the position of Vice President and Head of Medical Affairs at Sobi Inc., where he led their North American medical and scientific operations. Previously, Dr. Walt held the position of Medical Director at Biogen Canada where he built best-in-class medical teams and developed strong relationships with key clinical investigators in Canada.

“What inspired me to take on this role is a strong belief in the significant clinical benefits cannabis can offer patients suffering from serious conditions,” said Dr. Len Walt, Chief Medical Officer, CannTrust. “My goal is to develop a world-class team that will conduct industry leading scientific research to further our understanding of cannabis and its therapeutic potential.”